Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation

Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation

The original version of this Article contained errors in the author affiliations. Qingnan Zhao, Xueqing Xia, Longfei Huo and Shulin Li were incorrectly associated with Beijing Institute for Brain Disorders, 100069, Beijing, China.This has now been corrected in both the PDF and HTML versions of the A...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jun Yan, Qingnan Zhao, Konrad Gabrusiewicz, Ling-Yuan Kong, Xueqing Xia, Jian Wang, Martina Ott, Jingda Xu, R. Eric Davis, Longfei Huo, Ganesh Rao, Shao-Cong Sun, Stephanie S. Watowich, Amy B. Heimberger, Shulin Li
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/356a0bf00a73476186ba34ce68950918
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:356a0bf00a73476186ba34ce68950918
record_format dspace
spelling oai:doaj.org-article:356a0bf00a73476186ba34ce689509182021-12-02T15:35:57ZAuthor Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation10.1038/s41467-019-08770-52041-1723https://doaj.org/article/356a0bf00a73476186ba34ce689509182019-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-08770-5https://doaj.org/toc/2041-1723The original version of this Article contained errors in the author affiliations. Qingnan Zhao, Xueqing Xia, Longfei Huo and Shulin Li were incorrectly associated with Beijing Institute for Brain Disorders, 100069, Beijing, China.This has now been corrected in both the PDF and HTML versions of the Article.Jun YanQingnan ZhaoKonrad GabrusiewiczLing-Yuan KongXueqing XiaJian WangMartina OttJingda XuR. Eric DavisLongfei HuoGanesh RaoShao-Cong SunStephanie S. WatowichAmy B. HeimbergerShulin LiNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-1 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Jun Yan
Qingnan Zhao
Konrad Gabrusiewicz
Ling-Yuan Kong
Xueqing Xia
Jian Wang
Martina Ott
Jingda Xu
R. Eric Davis
Longfei Huo
Ganesh Rao
Shao-Cong Sun
Stephanie S. Watowich
Amy B. Heimberger
Shulin Li
Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
description The original version of this Article contained errors in the author affiliations. Qingnan Zhao, Xueqing Xia, Longfei Huo and Shulin Li were incorrectly associated with Beijing Institute for Brain Disorders, 100069, Beijing, China.This has now been corrected in both the PDF and HTML versions of the Article.
format article
author Jun Yan
Qingnan Zhao
Konrad Gabrusiewicz
Ling-Yuan Kong
Xueqing Xia
Jian Wang
Martina Ott
Jingda Xu
R. Eric Davis
Longfei Huo
Ganesh Rao
Shao-Cong Sun
Stephanie S. Watowich
Amy B. Heimberger
Shulin Li
author_facet Jun Yan
Qingnan Zhao
Konrad Gabrusiewicz
Ling-Yuan Kong
Xueqing Xia
Jian Wang
Martina Ott
Jingda Xu
R. Eric Davis
Longfei Huo
Ganesh Rao
Shao-Cong Sun
Stephanie S. Watowich
Amy B. Heimberger
Shulin Li
author_sort Jun Yan
title Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
title_short Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
title_full Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
title_fullStr Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
title_full_unstemmed Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
title_sort author correction: fgl2 promotes tumor progression in the cns by suppressing cd103+ dendritic cell differentiation
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/356a0bf00a73476186ba34ce68950918
work_keys_str_mv AT junyan authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT qingnanzhao authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT konradgabrusiewicz authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT lingyuankong authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT xueqingxia authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT jianwang authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT martinaott authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT jingdaxu authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT rericdavis authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT longfeihuo authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT ganeshrao authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT shaocongsun authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT stephanieswatowich authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT amybheimberger authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
AT shulinli authorcorrectionfgl2promotestumorprogressioninthecnsbysuppressingcd103dendriticcelldifferentiation
_version_ 1718386404041424896

Ejemplares similares